Fatigue VAS scores were significantly lower in the CBTH group at the end of treatment ( z , 5.81 ; P < .001 ) and at the 6-month follow-up ( z , 4.56 ; P < .001 ) , but not at the 4-week follow-up ( P < .07 ) .